Scilex (SCLXW) Stock Price, News & Analysis

Company Overview

Scilex Holding Company (NASDAQ: SCLXW) is a commercial-stage specialty pharmaceutical company focused on the development, acquisition and commercialization of non-opioid pain management therapies. Its lead product, ZTlido™ (lidocaine topical system 1.8%), is approved in the United States for the relief of neuropathic pain associated with post-herpetic neuralgia. Scilex’s core strategy is to address the growing need for non-addictive alternatives to traditional opioid analgesics by leveraging innovative topical and transdermal delivery technologies.

Beyond its marketed portfolio, Scilex maintains a pipeline of clinical and preclinical candidates targeting a range of acute and chronic pain indications. The company applies expertise in formulation science to optimize localized drug delivery, aiming to reduce systemic exposure and minimize side effects. Scilex also pursues strategic partnerships and licensing agreements to expand its product offerings and accelerate development timelines.

Headquartered in Fort Worth, Texas, Scilex operates primarily across the United States, supported by a dedicated commercial organization that collaborates with healthcare professionals to enhance patient access and education. The company’s leadership team combines deep experience in specialty pharmaceuticals, commercial execution and regulatory affairs, positioning Scilex to capitalize on unmet needs in the pain management market.

Key Stats

• Today's Range: $0.45 to $0.47
• 50-Day Range: $0.09 to $0.59
• 52-Week Range: $0.04 to $0.65
• Volume: 7,614 shs
• Average Volume: 10,777 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SCLXW Stock Analysis - Frequently Asked Questions

How have SCLXW shares performed this year?

Scilex's stock was trading at $0.21 at the start of the year. Since then, SCLXW stock has increased by 119.0% and is now trading at $0.46.

How do I buy shares of Scilex?

Shares of SCLXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SCLXW
• CIK: 1820190
• Web: www.scilexholding.com
• Phone: 650 516 4310
• Fax: N/A
• Employees: 105
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $44.24 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A